1-1 of 1
Sheng-Min Lan
Close
Sort by
Journal Articles

Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group

Clinical Trials & Observations
Tao Wu, Yong Yang, Su-Yu Zhu, Mei Shi, Hang Su, Ying Wang, Xia He, Li-Ming Xu, Zhi-Yong Yuan, Li-Ling Zhang, Gang Wu, Bao-Lin Qu, Li-Ting Qian, Xiao-Rong Hou, Fu-Quan Zhang, Yu-Jing Zhang, Yuan Zhu, Jian-Zhong Cao, Sheng-Min Lan, Jun-Xin Wu, Chen Hu, Shu-Nan Qi, Bo Chen, Ye-Xiong Li
Journal: Blood Advances
Blood Adv (2018) 2 (18): 2369–2377.
https://doi.org/10.1182/bloodadvances.2018021311
Published: 2018
Includes: Supplemental data